Endogenous K-ras signaling in erythroid differentiation

Cell Cycle

Volumn 6, Issue 16, 2007, Pages 1970-1973

  Zhang, Jing ^a,c   Lodish, Harvey F ^a,b  

^a WHITEHEAD INSTITUTE FOR BIOMEDICAL RESEARCH   (United States)

^b MASSACHUSETTS INSTITUTE OF TECHNOLOGY   (United States)

^c UNIVERSITY OF WISCONSIN MADISON   (United States)

Author keywords

Cytokine; Endogenous level; Erythroid differentiation; K ras; Signal transduction

Indexed keywords

ERYTHROPOIETIN; K RAS PROTEIN; PROTEIN BCL XL; PROTEIN KINASE B; RAF PROTEIN; RAL PROTEIN; STAT5 PROTEIN;

CANCER PATIENT; CELL DIFFERENTIATION; CELL PROLIFERATION; CELL SURVIVAL; CELL TRANSFORMATION; ERYTHROID CELL; ERYTHROPOIESIS; GENE EXPRESSION; GENE MUTATION; HUMAN; LIVER; MYELOID LEUKEMIA; NONHUMAN; ONCOGENE H RAS; ONCOGENE K RAS; ONCOGENE N RAS; REVIEW; SIGNAL TRANSDUCTION; STEM CELL;

EID: 34548208814     PISSN: 15384101     EISSN: 15514005     Source Type: Journal    
DOI: 10.4161/cc.6.16.4577     Document Type: Review

References (41)

1. Barbacid M. Ras genes. Annu Rev Biochem 1987; 56:779-827.
2. Pells S, Divjak M, Romanowski P, Impey H, Hawkins NJ, Clarke AR, Hooper ML, Williamson DJ. Developmentally-regulated expression of murine K-ras isoforms. Oncogene 1997; 15:1781-6.
3. Muller R, Slamon DJ, Tremblay JM, Cline MJ, Verma IM. Differential expression of cellular oncogenes during pre- and postnatal development of the mouse. Nature 1982; 299:640-4.
4. Muller R, Slamon DJ, Adamson ED, Tremblay JM, Muller D, Cline MJ, Verma IM. Transcription of c-onc genes c-rasKi and c-fms during mouse development. Mol Cell Biol 1983; 3:1062-9.
5. Slamon DJ, Cline MJ. Expression of cellular oncogenes during embryonic and fetal development of the mouse. Proc Natl Acad Sci USA 1984; 81:7141-5.
6. Leon J, Guerrero I, Pellicer A. Differential expression of the ras gene family in mice. Mol Cell Biol 1987; 7:1535-40.
7. Polakis P, McCormick F. Structural requirements for the interaction of p21ras with GAP, exchange factors, and its biological effector target. J Biol Chem 1993; 268:9157-60.
8. Umanoff H, Edelmann W, Pellicer A, Kucherlapati R. The murine N-ras gene is not essential for growth and development. Proc Natl Acad Sci USA 1995; 92:1709-13.
9. Esteban LM, Vicario-Abejon C, Fernandez-Salguero P, Fernandez-Medarde A, Swaminathan N, Yienger K, Lopez E, Malumbres M, McKay R, Ward JM, Pellicer A, Santos E. Targeted genomic disruption of H-ras and N-ras, individually or in combination, reveals the dispensability of both loci for mouse growth and development. Mol Cell Biol 2001; 21:1444-52.
10. Johnson L, Greenbaum D, Cichowski K, Mercer K, Murphy E, Schmitt E, Bronson RT, Umanoff H, Edelmann W, Kucherlapati R, Jacks T. K-ras is an essential gene in the mouse with partial functional overlap with N-ras. Genes Dev 1997; 11:2468-81.
11. Koera K, Nakamura K, Nakao K, Miyoshi J, Toyoshima K, Hatta T, Otani H, Aiba A, Katsuki M. K-ras is essential for the development of the mouse embryo. Oncogene 1997; 15:1151-9.
12. Bos JL. Ras oncogenes in human cancer: A review. Cancer Res 1989; 49:4682-9.
13. Adjei AA. Blocking oncogenic Ras signaling for cancer therapy. J Natl Cancer Inst 2001; 93:1062-74.
14. Serrano M, Lin AW, McCurrach ME, Beach D, Lowe SW. Oncogenic ras provokes premature cell senescence associated with accumulation of p53 and p16INK4a. Cell 1997; 88:593-602.
15. Zhang J, Socolovsky M, Gross AW, Lodish HF. Role of Ras signaling in erythroid differentiation of mouse fetal liver cells: Functional analysis by a flow cytometry-based novel culture system. Blood 2003; 102:3938-46.
16. Tuveson DA, Shaw AT, Willis NA, Silver DP, Jackson EL, Chang S, Mercer KL, Grochow R, Hock H, Crowley D, Hingorani SR, Zaks T, King C, Jacobetz MA, Wang L, Bronson RT, Orkin SH, DePinho RA, Jacks T. Endogenous oncogenic K-ras(G12D) stimulates proliferation and widespread neoplastic and developmental defects. Cancer Cell 2004; 5:375-87.
17. Ghaffari S, Huang L, Zhang J, Lodish H. Erythropoietin receptor signaling processes. In: Molineux G, Foote M, Elliott S, eds. Erythropoietins and erythropoiesis: Molecular, cellular, preclinical, and clinical biology. Basel: Birkhauser Publishing, 2003:65-85.
18. -/- mice due to decreased survival of early erythroblasts. Blood 2001; 98:3261-73.
19. -/- mice: A direct role for Stat5 in Bcl-X(L) induction. Cell 1999; 98:181-91.
20. Zang H, Sato K, Nakajima H, McKay C, Ney PA, Ihle JN. The distal region and receptor tyrosines of the Epo receptor are non- essential for in vivo erythropoiesis. Embo J 2001; 20:3156-66.
21. Snow JW, Abraham N, Ma MC, Abbey NW, Herndier B, Goldsmith MA. STAT5 promotes multilineage hematolymphoid development in vivo through effects on early hematopoietic progenitor cells. Blood 2002; 99:95-101.
22. Cho H, Mu J, Kim JK, Thorvaldsen JL, Chu Q, Crenshaw IIIrd EB, Kaestner KH, Bartolomei MS, Shulman GI, Birnbaum MJ. Insulin resistance and a diabetes mellitus-like syndrome in mice lacking the protein kinase Akt2 (PKB beta). Science 2001; 292:1728-31.
23. Cho H, Thorvaldsen JL, Chu Q, Feng F, Birnbaum MJ. Akt1/PKBalpha is required for normal growth but dispensable for maintenance of glucose homeostasis in mice. J Biol Chem 2001; 276:38349-52.
24. Chen WS, Xu PZ, Gottlob K, Chen ML, Sokol K, Shiyanova T, Roninson I, Weng W, Suzuki R, Tobe K, Kadowaki T, Hay N. Growth retardation and increased apoptosis in mice with homozygous disruption of the Akt1 gene. Genes Dev 2001; 15:2203-8.
25. Easton RM, Cho H, Roovers K, Shineman DW, Mizrahi M, Forman MS, Lee VM, Szabolcs M, de Jong R, Oltersdorf T, Ludwig T, Efstratiadis A, Birnbaum MJ. Role for Akt3/protein kinase Bgamma in attainment of normal brain size. Mol Cell Biol 2005; 25:1869-78.
26. Ueki K, Yballe CM, Brachmann SM, Vicent D, Watt JM, Kahn CR, Cantley LC. Increased insulin sensitivity in mice lacking p85beta subunit of phosphoinositide 3-kinase. Proc Natl Acad Sci USA 2002; 99:419-24.
27. Huddleston H, Tan B, Yang FC, White H, Wenning MJ, Orazi A, Yoder MC, Kapur R, Ingram DA. Functional p85alpha gene is required for normal murine fetal erythropoiesis. Blood 2003; 102:142-5.
28. Carroll MP, Spivak JL, McMahon M, Weich N, Rapp UR, May WS. Erythropoietin induces Raf-1 activation and Raf-1 is required for erythropoietin-mediated proliferation. J Biol Chem 1991; 266:14964-9.
29. Sakamoto H, Kitamura T, Yoshimura A. Mitogen-activated protein kinase plays an essential role in the erythropoietin-dependent proliferation of CTLL-2 cells. J Biol Chem 2000; 275:35857-62.
30. Miura Y, Miura O, Ihle JN, Aoki N. Activation of the mitogen-activated protein kinase pathway by the erythropoietin receptor. J Biol Chem 1994; 269:29962-9.
31. Eshghi S, Vogelezang MG, Hynes RO, Griffith LG, Lodish HF. A 4b1 integrin and erythropoietin mediate temporally distinct steps in terminal erythroid differentiation and proliferation. J Cell Biology 2007, (in press).
32. Zhang J, Lodish HF. Constitutive activation of the MEK/ERK pathway mediates all effects of oncogenic H-ras expression in primary erythroid progenitors. Blood 2004; 104:1679-87.
33. Zhang J, Liu Y, Beard C, Tuveson DA, Jaenisch R, Jacks TE, Lodish HF. Expression of oncogenic K-ras from its endogenous promoter leads to a partial block of erythroid differentiation and hyperactivation of cytokine-dependent signaling pathways. Blood 2007.
34. Braun BS, Tuveson DA, Kong N, Le DT, Kogan SC, Rozmus J, Le Beau MM, Jacks TE, Shannon KM. Somatic activation of oncogenic K-ras in hematopoietic cells initiates a rapidly fatal myeloproliferative disorder. Proc Natl Acad Sci USA 2004; 101:597-602.
35. Chan IT, Kutok JL, Williams IR, Cohen S, Kelly L, Shigematsu H, Johnson L, Akashi K, Tuveson DA, Jacks T, Gilliland DG. Conditional expression of oncogenic K-ras from its endogenous promoter induces a myeloproliferative disease. J Clin Invest 2004; 113:528-38.
36. Zhang J, Lodish HF. Identification of K-ras as the major regulator for cytokine-dependent Akt activation in erythroid progenitors in vivo. Proc Natl Acad Sci USA 2005; 102:14605-10.
37. Jaumot M, Yan J, Clyde-Smith J, Sluimer J, Hancock JF. The linker domain of the Ha-Ras hypervariable region regulates interactions with exchange factors, Raf-1 and phosphoinositide 3-kinase. J Biol Chem 2002; 277:272-8.
38. Booden MA, Sakaguchi DS, Buss JE. Mutation of Ha-Ras C terminus changes effector pathway utilization. J Biol Chem 2000; 275:23559-68.
39. Soriano P. Generalized lacZ expression with the ROSA26 Cre reporter strain. Nat Genet 1999; 21:70-1.
40. Beard C, Hochedlinger K, Plath K, Wutz A, Jaenisch R. Efficient method to generate single-copy transgenic mice by site-specific integration in embryonic stem cells. Genesis 2006; 44:23-8.
41. Schonig K, Schwenk F, Rajewsky K, Bujard H. Stringent doxycycline dependent control of CRE recombinase in vivo. Nucleic Acids Res 2002; 30:e134.